基本信息
浏览量:9
职业迁徙
个人简介
Dr. Lawrence's group efforts are focused on the synthesis of new anticancer agents. The goal of the laboratory is to design and develop synthetic methodology to provide small organic molecules to act as selective anticancer agents against a range of molecular targets. Our research concerns the development of new anticancer drugs using a combination of synthetic chemistry and natural product isolation; it involves a very productive collaborative program incorporating both chemistry and biology. One aspect of our research concerns the design and function of tumor vasculature targeting anticancer agents that interact with the elements of the cytoskeleton. We are investigating the nature of the colchicine-binding site of ???-tubulin by the design of appropriate photo-affinity labeling agents and molecular modeling methods. Our laboratory is developing new anticancer agents based on agents related to combretastatins. These agents show potent activity in vitro and in vivo and are currently being prepared via serial and parallel synthesis for evaluation as tumor vasculature targeting drugs. The program also involves the structure activity study of complex derivatives of cucurbaticins. Natural products feature highly in our research, particularly as lead structures in the drug development process. The discovery of new bioactive natural products can often be a laborious venture. We are therefore developing novel natural product isolation techniques to help identify new structures with anticancer activity. Our research also concerns the development of novel synthetic methodology. This has included methods for the clean asymmetric reduction of ketones using polymeric siloxanes. We are now developing new reagents for use in design and preparation of combinatorial libraries. Our a long-standing interest in multi-component reactions based on vicarious nucleophilic aromatic substitution now provides new processes for the rapid construction of molecular scaffolds for the development of combinatorial libraries for use in the high throughput screening lab. Key words: Drug discovery, organic synthesis, bioorganic and medicinal chemistry, combinatorial chemistry, natural products, peptidomimetics.
研究兴趣
论文共 179 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2023)
Marilena Tauro,Tao Li,Mark Meads,Praneeth Sudalagunta, Raghunandan Alugubelli,Nicholas Lawrence, Ernst Schinbrunn,Ryan Bishop,Harshani Lawrence,Ken Shain,Conor Lynch
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S155-S155
Angelie Matar, Yuliya Marusyk,Sujeewa Ranatunga, Tegan Rowsell, Narmin Amin, Hannah Walker,Timothy Tran, Kathy Yang,Derek Duckett,Gary Reuther,Harshani Lawrence,Nicholas Lawrence
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
crossref(2023)
crossref(2023)
Mithila Sawant,Kiran Mahajan,Arun Renganathan,Cody Weimholt,Jingqin Luo,Vandna Kukshal,Joseph M Jez, Myung Sik Jeon,Bo Zhang,Tiandao Li,Bin Fang,Yunting Luo,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn